November 22, 2018 / 5:45 AM / a year ago

Swiss stocks - Factors to watch on Nov. 22

BERLIN, Nov 22 (Reuters) - The Swiss blue-chip SMI was seen opening down 0.1 percent at 8,833 points on Thursday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:


Roche said its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as part of a combination treatment for newly diagnosed patients with a form of leukaemia.


An Italian administrative court annulled fines on several phone operators, including Swisscom’s Fastweb, which had been imposed last year by communications regulator AGCOM over a billing practice.


* Energiedienst Holding announced its EBIT profit would be much lower than expected in the second half of the year.

* EFG International said it has appointed Lenja Lascari as the new CEO for Luxembourg.

* Valora said Insa Klasing and Sascha Zahnd would stand for election to its board of directors at its Annual General Meeting on 29 March 2019.

* Dufry said it has won a contract for five Hudson convenience stores at Zurich Airport.

* Carlo Gavazzi Holding said its first half net profit rose 12.2 percent to 4.6 million Swiss francs ($4.63 million).


* Swatch Group - Barclays cuts to “sector perform” from “outperform”


Q3 Industrial production data due at 0815 GMT.

$1 = 0.9933 Swiss francs Reporting by Berlin Speed Desk

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below